Your browser doesn't support javascript.
Persistent reduction of retinal microvascular vessel density in patients with moderate and severe COVID-19 disease.
Banderas García, Sandra; Aragón, David; Azarfane, Brahim; Trejo, Fernando; Garrell-Salat, Xavier; Sánchez-Montalvá, Adrián; Otero-Romero, Susana; Garcia-Arumi, Jose; Zapata, Miguel Angel.
  • Banderas García S; Department of Ophthalmology, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
  • Aragón D; Department of Ophthalmology, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
  • Azarfane B; Department of Ophthalmology, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
  • Trejo F; Department of Ophthalmology, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
  • Garrell-Salat X; Department of Ophthalmology, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
  • Sánchez-Montalvá A; Infectious Diseases Department, Universitat Autònoma de Barcelona, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Otero-Romero S; Preventive Medicine and Epidemiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Garcia-Arumi J; Department of Ophthalmology, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
  • Zapata MA; IMO, Institute of Ocular Microsurgery, Barcelona, Spain.
BMJ Open Ophthalmol ; 7(1): e000867, 2022.
Article in English | MEDLINE | ID: covidwho-1807429
ABSTRACT

OBJECTIVE:

This study aims to analyse the possible recovery or worsening in retinal microvasculature after 8 months in a previously studied COVID-19 cohort. METHODS AND

ANALYSIS:

A cross-sectional case-control study and a prospective longitudinal cohort study. Participants were the subjects of our previous study who re-enrolled for a new examination including a fundus photograph (retinography), an optical coherence tomography (OCT) scan and an OCT angiography. COVID-19 diagnosed patients were divided into three groups group 1 mild disease, asymptomatic/paucisymptomatic subjects who received outpatient care; group 2 moderate disease and group 3 severe disease, both of which required hospital admission because of pneumonia. Statistical analyses were performed using SPSS software (V.23.0). Cross-sectional intergroup differences were analysed by means of analysis of variance for normally distributed variables and the Kruskal-Wallis test for non-normally distributed ones. In reference to the prospective part of the study (intragroup differences, baseline with 8-month comparison), a paired t-test was used for normally distributed data and Wilcoxon signed ranks sum for non-normally distributed data.

RESULTS:

The fovea-centered superficial and deep vascular densities were significantly diminished in severe cases compared with mild cases (p=0.004; p=0.003, respectively, for superficial and deep) and to controls (p=0.014; p=0.010), also in moderate cases to mild group (p=0.004; p=0.003) and to controls (p=0.012; p=0.024). In the longitudinal study, no significant statistical differences were found between baseline and 8-month follow-up vessel density values.

CONCLUSION:

We demonstrated persistent reduction in the central vascular area over time in patients with moderate and severe COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Open Ophthalmol Year: 2022 Document Type: Article Affiliation country: Bmjophth-2021-000867

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Open Ophthalmol Year: 2022 Document Type: Article Affiliation country: Bmjophth-2021-000867